Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × beta-Thalassemia × luspatercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Anemia 2 beta-Thalassemia 1 Thrombocytosis 1 Primary Myelofibrosis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02604433 2023-04-18

BELIEVE

Celgene

Phase 3 Completed

336 enrolled 38 charts 1 FDA

beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡